Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Comprehensive Analysis Revealing BUB1B as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma. | Int J Mol Sci | 2025 | 40076684 | PubTator, text mining | PubMed |
| Bulk transcriptome and single-nucleus RNA sequencing analyses highlight the role of recombination activating 1 in non-alcoholic fatty liver disease. | Int J Biol Macromol | 2025 | 40074128 | PubTator, text mining | PubMed |
| BUB1 serves as a biomarker for poor prognosis in liver hepatocellular carcinoma. | BMC Immunol | 2025 | 40069598 | PubTator, text mining | PubMed |
| Pathogenic variants of BUB1 and BUBR1 genes are not prioritized in screening tests of couples with aborted aneuploid fetuses. | Mol Biol Res Commun | 2025 | 40028477 | PubTator, text mining | PubMed |
| Hybrid female sterility due to cohesin protection errors in oocytes. | bioRxiv | 2025 | 40027736 | PubTator, text mining | PubMed |
| Targeting the AURKB-MAD2L2 Axis Disrupts the DNA Damage Response and Glycolysis to Inhibit Colorectal Cancer Progression. | Front Biosci (Landmark Ed) | 2025 | 40018943 | PubTator, text mining | PubMed |
| Identification of Novel lncRNAs Related to Colorectal Cancer Through Bioinformatics Analysis. | Biomed Res Int | 2025 | 39949372 | PubTator, text mining | PubMed |
| Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component. | Am J Surg Pathol | 2025 | 39931796 | PubTator, text mining | PubMed |
| PICH impacts the spindle assembly checkpoint via its DNA translocase and SUMO-interaction activities. | Life Sci Alliance | 2025 | 39919802 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. | Curr Genomics | 2025 | 39911278 | PubTator, text mining | PubMed |
| Exploring the mechanism and drug candidates of alveolar echinococcosis affecting liver fibrosis through analysis of existing microarray data. | Acta Trop | 2025 | 39863141 | PubTator, text mining | PubMed |
| Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach. | Sci Rep | 2025 | 39848951 | PubTator, text mining | PubMed |
| Expression and prognostic impact of hypoxia- and immune escape-related genes in triple-negative breast cancer: A comprehensive analysis. | Int Immunopharmacol | 2025 | 39689602 | PubTator, text mining | PubMed |
| Effect of COL11A1 on oral squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2025 | 39631528 | PubTator, text mining | PubMed |
| Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores. | Cancer Sci | 2025 | 39604214 | PubTator, text mining | PubMed |
| The Predictive Value of BUB1 in the Prognosis of Oral Squamous Cell Carcinoma. | Int Dent J | 2025 | 39147662 | PubTator, text mining | PubMed |
| Recent advances in plant kinetochore research. | Front Cell Dev Biol | 2024 | 39911184 | PubTator, text mining | PubMed |
| Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer. | Sci Rep | 2024 | 39733078 | PubTator, text mining | PubMed |
| [Effect of overexpression of aldehyde dehydrogenase family member A2 on hypertrophic growth and proliferation of cardiomyocytes]. | Sheng Wu Gong Cheng Xue Bao | 2024 | 39722524 | PubTator, text mining | PubMed |
| Identification of key signaling pathways and novel computational drug target for oral cancer, metabolic disorders and periodontal disease. | J Genet Eng Biotechnol | 2024 | 39674633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=7